Pierre‐Jean Ferron

790 total citations
32 papers, 589 citations indexed

About

Pierre‐Jean Ferron is a scholar working on Molecular Biology, Pharmacology and Epidemiology. According to data from OpenAlex, Pierre‐Jean Ferron has authored 32 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Pharmacology and 7 papers in Epidemiology. Recurrent topics in Pierre‐Jean Ferron's work include Metabolomics and Mass Spectrometry Studies (9 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Liver Disease Diagnosis and Treatment (7 papers). Pierre‐Jean Ferron is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (9 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Liver Disease Diagnosis and Treatment (7 papers). Pierre‐Jean Ferron collaborates with scholars based in France, Switzerland and Canada. Pierre‐Jean Ferron's co-authors include Thomas Gicquel, Brendan Le Daré, Valérie Fessard, Ludovic Le Hégarat, Isabelle Morel, Kevin Hogeveen, Bruno Clément, Bernard Fromenty, Romain Pelletier and Olivier Pible and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Hazardous Materials and Scientific Reports.

In The Last Decade

Pierre‐Jean Ferron

31 papers receiving 579 citations

Peers

Pierre‐Jean Ferron
Shaun M. K. McKinnie United States
Mostafa Z. Badr United States
Yuping Chen United States
Lisbeth K. Siddens United States
Troy D. Hubbard United States
Shaun M. K. McKinnie United States
Pierre‐Jean Ferron
Citations per year, relative to Pierre‐Jean Ferron Pierre‐Jean Ferron (= 1×) peers Shaun M. K. McKinnie

Countries citing papers authored by Pierre‐Jean Ferron

Since Specialization
Citations

This map shows the geographic impact of Pierre‐Jean Ferron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre‐Jean Ferron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre‐Jean Ferron more than expected).

Fields of papers citing papers by Pierre‐Jean Ferron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre‐Jean Ferron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre‐Jean Ferron. The network helps show where Pierre‐Jean Ferron may publish in the future.

Co-authorship network of co-authors of Pierre‐Jean Ferron

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre‐Jean Ferron. A scholar is included among the top collaborators of Pierre‐Jean Ferron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre‐Jean Ferron. Pierre‐Jean Ferron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Léger, Thibaut, Pierre‐Jean Ferron, Tahar Bouceba, et al.. (2024). Chlordecone-induced hepatotoxicity and fibrosis are mediated by the proteasomal degradation of septins. Journal of Hazardous Materials. 476. 135177–135177. 3 indexed citations
2.
Ferron, Pierre‐Jean, Romain Pelletier, Julie Massart, et al.. (2024). Role of CYP2D6 polymorphisms in tramadol metabolism in a context of co-medications and overweight. Food and Chemical Toxicology. 196. 115192–115192.
3.
4.
Pelletier, Romain, Brendan Le Daré, Pierre‐Jean Ferron, et al.. (2023). Identification, synthesis and quantification of eutylone consumption markers in a chemsex context. Archives of Toxicology. 98(1). 151–158. 8 indexed citations
5.
Pelletier, Romain, Nicolas Fabresse, Pierre‐Jean Ferron, et al.. (2023). In silico and in vitro metabolism studies of the new synthetic opiate AP-237 (bucinnazine) using bioinformatics tools. Archives of Toxicology. 98(1). 165–179. 4 indexed citations
6.
Massart, Julie, Daniel Catheline, Vincent Rioux, et al.. (2023). 3D multi-cell-type liver organoids: A new model of non-alcoholic fatty liver disease for drug safety assessments. Toxicology in Vitro. 94. 105728–105728. 23 indexed citations
7.
Lan, Annaïg, Mireille Andriamihaja, Pierre‐Jean Ferron, et al.. (2023). Mitochondrial remodeling and energy metabolism adaptations in colonic crypts during spontaneous epithelial repair after colitis induction in mice. Free Radical Biology and Medicine. 205. 224–233. 11 indexed citations
8.
Pelletier, Romain, et al.. (2022). Arylcyclohexylamine Derivatives: Pharmacokinetic, Pharmacodynamic, Clinical and Forensic Aspects. International Journal of Molecular Sciences. 23(24). 15574–15574. 13 indexed citations
9.
Pelletier, Romain, Thomas Gicquel, Pierre‐Jean Ferron, et al.. (2022). A Transversal Approach Combining In Silico, In Vitro and In Vivo Models to Describe the Metabolism of the Receptor Interacting Protein 1 Kinase Inhibitor Sibiriline. Pharmaceutics. 14(12). 2665–2665. 3 indexed citations
11.
Daré, Brendan Le, Romain Pelletier, Pierre‐Jean Ferron, et al.. (2022). Carbofuran self-poisoning: forensic and analytic investigations in twins and literature review. International Journal of Legal Medicine. 136(6). 1585–1596. 7 indexed citations
12.
Ferron, Pierre‐Jean, Brendan Le Daré, Clara Steichen, et al.. (2021). Molecular Networking for Drug Toxicities Studies: The Case of Hydroxychloroquine in COVID-19 Patients. International Journal of Molecular Sciences. 23(1). 82–82. 11 indexed citations
13.
Pelletier, Romain, et al.. (2021). New psychoactive substance cocktail in an intensive care intoxication case elucidated by molecular networking. Clinical Toxicology. 60(1). 122–125. 18 indexed citations
14.
Gicquel, Thomas, Romain Pelletier, Camille Richeval, et al.. (2021). Metabolite elucidation of 2‐fluoro‐deschloroketamine (2F‐DCK) using molecular networking across three complementary in vitro and in vivo models. Drug Testing and Analysis. 14(1). 144–153. 19 indexed citations
15.
Daré, Brendan Le, et al.. (2021). In vivo and in vitro α-amanitin metabolism studies using molecular networking. Toxicology Letters. 346. 1–6. 25 indexed citations
16.
Daré, Brendan Le, Pierre‐Jean Ferron, Catherine Ribault, et al.. (2021). A therapeutic oxygen carrier isolated from Arenicola marina decreases amanitin-induced hepatotoxicity. Toxicon. 200. 87–91. 7 indexed citations
17.
Ferron, Pierre‐Jean, Thomas Gicquel, Bruno Mégarbane, Bruno Clément, & Bernard Fromenty. (2020). Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?. Biochimie. 179. 266–274. 35 indexed citations
18.
Allard, Julien, Simon Bucher, Julie Massart, et al.. (2020). Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity. Cell Biology and Toxicology. 37(2). 151–175. 31 indexed citations
19.
Ferron, Pierre‐Jean, et al.. (2019). Evaluation of immunomodulatory activities of essential oils by high content analysis. Journal of Biotechnology. 303. 65–71. 19 indexed citations
20.
Ferron, Pierre‐Jean, Kevin Hogeveen, Georges de Sousa, et al.. (2016). Modulation of CYP3A4 activity alters the cytotoxicity of lipophilic phycotoxins in human hepatic HepaRG cells. Toxicology in Vitro. 33. 136–146. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026